Utility of human leukocyte antigen-B*58-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utility of human leukocyte antigen-B*58

Published:2019-01 Issue:1 Volume:29 Page:1-8
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Ke Ching-Hua,Chung Wen-Hung,Tain You-Lin,Huang Yaw-Bin,Wen Yen-Hsia,Chuang Hung-Yi,Hsu Chien-Ning

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference23 articles.

1. Pharmacogenomics-based point-of-care clinical decision support significantly alters drug prescribing;O’Donnell;Clin Pharmacol Ther,2017

2. Prevalence and implications of cytochrome P450 substrates in Massachusetts hospital discharges;McCoy;Pharmacogenomics J,2017

3. Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions;Chen;Neurology,2014

4. The global burden of gout: estimates from the Global Burden of Disease 2010 study;Smith;Ann Rheum Dis,2014

5. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia;Khanna;Arthritis Car Res (Hoboken,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review;Therapeutic Drug Monitoring;2024-09-11

2. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

3. Genetic associations of human leukocyte antigen alleles in cutaneous delayed drug hypersensitivity reactions: An updated review;Dermatologica Sinica;2023

4. A lifetime economic research of universal HLA-B*58:01 genotyping or febuxostat initiation therapy in Chinese gout patients with mild to moderate chronic kidney disease;Pharmacogenetics and Genomics;2022-12-09

5. Advances in the Pathomechanisms of Delayed Drug Hypersensitivity;Immunology and Allergy Clinics of North America;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3